Ryan Specialty Holdings, INC
Market Movers (8-K)
NYSE
Ryan Specialty Holdings, Inc. announced its second quarter 2026 financial results, reporting revenue growth and a quarterly dividend declaration.
NYSE
Ryan Specialty Holdings, Inc. announced an increase to its share repurchase program, authorizing an additional $300 million for stock buybacks.
NYSE
Ryan Specialty Holdings, Inc. shareholders approved the election of directors, ratified the appointment of Deloitte & Touche LLP, and supported executive compensation.
NYSE
Ryan Specialty Holdings, Inc. has entered into an option settlement agreement with the Ryan Stock Option Trust to ensure net-neutrality for new employee stock option grants.
NYSE
Ryan Specialty reported strong first-quarter 2026 growth with revenue up 15.2% and declared a quarterly dividend of $0.13 per share.
NYSE
Ryan Specialty Holdings, Inc. announced its fourth quarter and full year 2025 results, revealing strong revenue growth alongside declining net income, and initiated a three-year restructuring program and a $300 million share repurchase authorization.
Capital raise
Quarterly Earnings (10-Q)
NYSE
Ryan Specialty Holdings, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting an increase in total revenue driven by organic growth and acquisitions.
Worse than expected
NYSE
Ryan Specialty Holdings, Inc. announced a significant increase in third-quarter revenue and net income, driven by robust organic growth and strategic acquisitions, despite a decline in nine-month net income due to non-cash tax expenses.
NYSE
10-Q: Ryan Specialty Reports Strong Revenue Growth Amidst Acquisition Spree, GAAP Net Income Declines
Ryan Specialty Holdings, Inc. announced a significant increase in total revenue and adjusted earnings for the second quarter and first half of 2025, driven by strategic acquisitions, despite a notable slowdown in organic revenue growth and a decline in GAAP net income for the six-month period.
Capital raise
NYSE
Ryan Specialty Holdings' Q1 2025 results show a 25% increase in revenue, influenced by recent acquisitions and evolving market dynamics in the E&S sector.
Worse than expected
NYSE
Ryan Specialty Holdings, Inc. demonstrates significant revenue growth in the third quarter of 2024, driven by strategic acquisitions and organic expansion across its specialty distribution channels.
Better than expected
Capital raise
NYSE
Ryan Specialty Holdings reported a significant increase in revenue and net income for the second quarter of 2024, fueled by organic growth and strategic acquisitions.
Better than expected
Capital raise
Annual Reports (10-K)
NYSE
Ryan Specialty Holdings, Inc. announced a 21.3% increase in total revenue for 2025, alongside a new three-year restructuring program and an increased quarterly dividend.
NYSE
Ryan Specialty Holdings, Inc. announces a robust 2024 performance driven by expansion in the Excess and Surplus (E&S) market and successful integration of strategic acquisitions.
Better than expected
NYSE
Ryan Specialty Holdings, a specialty insurance service provider, released its 2023 annual report, showcasing a 20.4% revenue increase and growth within the Excess and Surplus (E&S) market.
Better than expected
Insider Trading (Form 4)
NYSE
Janice M Hamilton, Chief Financial Officer of Ryan Specialty Holdings, Inc., reported multiple transactions in common stock on July 22, 2026.
NYSE
Director Anthony J. Kuczinski of Ryan Specialty Holdings, Inc. reported the purchase of 3,000 shares of Class A Common Stock.
NYSE
Director John W. Rogers Jr. purchased 7,500 shares of Ryan Specialty Holdings, Inc. at an average price of $35.16 per share.
NYSE
Patrick G. Ryan, Executive Chairman and 10% owner of Ryan Specialty Holdings, Inc., reported the acquisition of 120,000 shares of Class A Common Stock.
NYSE
Janice M. Hamilton, Chief Financial Officer of Ryan Specialty Holdings, Inc., acquired 6,300 shares of Class A Common Stock.
NYSE
Ryan Specialty Holdings EVP & General Counsel Mark Stephen Katz reported a purchase of 3,215 shares of Class A Common Stock.
Proxy Statements (Def-14A)
NYSE
Ryan Specialty Holdings, Inc. reports strong 2025 financial results with over $3 billion in revenue, 21% year-over-year growth, and announces a $300 million share repurchase program and an 8% dividend increase.
Worse than expected
NYSE
Ryan Specialty Holdings has filed a definitive proxy statement with the SEC.
NYSE
Ryan Specialty Holdings seeks stockholder approval for significant amendments to its corporate governance structure, including declassifying the board and modifying voting rights.
NYSE
DEFA14A: Ryan Specialty Holdings Sets Date for Annual Stockholders Meeting, Seeks Approval on Key Proposals
Ryan Specialty Holdings will hold its annual stockholders meeting on April 30, 2024, seeking votes on director elections, auditor ratification, and executive compensation.
NYSE
DEF 14A: Ryan Specialty Holdings Reports Strong 2023 Performance and Outlines Strategic Priorities for 2024
Ryan Specialty Holdings' 2024 Proxy Statement highlights a successful 2023 with double-digit growth across all specialties and strategic M&A activity, setting an ambitious outlook for 2024.
Better than expected
Schedule 13G - Passive Investments
NYSE
Capital World Investors has filed an amendment to its Schedule 13G, reporting zero beneficial ownership of common stock in Ryan Specialty Holdings, Inc. as of March 31, 2026.
NYSE
Vulcan Value Partners, LLC has reported beneficial ownership of 5.12% of Ryan Specialty Holdings, Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Ryan Specialty Holdings Inc. following an internal realignment.
NYSE
Patrick G. Ryan, Shirley W. Ryan, and Robert J. W. Ryan collectively report beneficial ownership of 53.38% of Ryan Specialty Holdings, Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
Kayne Anderson Rudnick Investment Management, LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 3.4% of Ryan Specialty Holdings, Inc.'s Class A Common Stock as of December 31, 2024.